Brian Wong, M.D., PH.D., President and Chief Executive Officer, RAPT Therapeutics

Brian Wong, M.D., PH.D., President and Chief Executive Officer, RAPT Therapeutics

Brian Wong, M.D., PH.D., President and Chief Executive Officer, RAPT Therapeutics

Dr. Wong is a physician/scientist with 20 plus years of experience leading organizations at the forefront of innovative drug development. Prior to RAPT, he served as Senior Vice President, Research, and Head of Immuno-Oncology at Five Prime Therapeutics. Prior to FivePrime, Dr. Wong served as Director in the Inflammation Disease Biology Area at Roche. There, he led the discovery and supported the development of Roche’s autoimmune disease portfolio, consisting of more than 20 biologics and small-molecule programs from discovery to late-stage clinical development and through approval. Prior to Roche, he held various leadership roles at Rigel Pharmaceuticals, where he identified and developed clinical candidates for allergic, autoimmune and respiratory disorders, including Tavalisse™.

Dr. Wong received his M.D. from the Weill Cornell Medical College and his Ph.D. in Immunology from Rockefeller University.